| John J Gullo, MD | |
|
5008 Brittonfield Pkwy, Suite 700, East Syracuse, NY 13057-9248 | |
| (315) 472-7504 | |
| (315) 479-8639 |
| Full Name | John J Gullo |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 52 Years |
| Location | 5008 Brittonfield Pkwy, East Syracuse, New York |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700865243 | NPI | - | NPPES |
| 00602671 | Medicaid | NY |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | 137981-1 (New York) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Chans Hospice Care | Brunswick, ME | Hospice |
| Maine Medical Center | Portland, ME | Hospital |
| Mid Coast Hospital | Brunswick, ME | Hospital |
| Stephens Memorial Hospital | Norway, ME | Hospital |
| Penobscot Bay Medical Center | Rockport, ME | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Maine Medical Partners | 9335043967 | 789 |
| Mainehealth | 7517860588 | 2067 |
News Archive
Scientists at the University of Liverpool, supported by the British Heart Foundation, are studying blood flow in the brain to further medical understanding of cardiovascular disease.
...despite the fact that virtually all of them could benefit from those drugs, a new University of Michigan study finds. And even among those with the most to gain from the medicines, the rate of use barely reaches 53 percent.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
MARCH 2010 proved to change the diet industry forever when HCG Platinum launched their product in Anaheim, California at the Natural Products Expo West. With growing consumer concerns about credible weight loss products, Platinum perfected the HCG hormone diet by adding three amino acids to the formula, making it not only the most effective diet product on the market, but also the safest.
The loss of a gene known as INPP5A could predict the onset, and track the progression, of an aggressive type of skin cancer, according to a study published today by the Mayo Clinic, Arizona Cancer Center, and the Translational Genomics Research Institute (TGen).
› Verified 5 days ago
| Entity Name | St Marys Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1447226584 PECOS PAC ID: 0042107120 Enrollment ID: O20040303000236 |
News Archive
Scientists at the University of Liverpool, supported by the British Heart Foundation, are studying blood flow in the brain to further medical understanding of cardiovascular disease.
...despite the fact that virtually all of them could benefit from those drugs, a new University of Michigan study finds. And even among those with the most to gain from the medicines, the rate of use barely reaches 53 percent.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
MARCH 2010 proved to change the diet industry forever when HCG Platinum launched their product in Anaheim, California at the Natural Products Expo West. With growing consumer concerns about credible weight loss products, Platinum perfected the HCG hormone diet by adding three amino acids to the formula, making it not only the most effective diet product on the market, but also the safest.
The loss of a gene known as INPP5A could predict the onset, and track the progression, of an aggressive type of skin cancer, according to a study published today by the Mayo Clinic, Arizona Cancer Center, and the Translational Genomics Research Institute (TGen).
› Verified 5 days ago
| Entity Name | Waldo County General Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1841397932 PECOS PAC ID: 2163332883 Enrollment ID: O20040428001058 |
News Archive
Scientists at the University of Liverpool, supported by the British Heart Foundation, are studying blood flow in the brain to further medical understanding of cardiovascular disease.
...despite the fact that virtually all of them could benefit from those drugs, a new University of Michigan study finds. And even among those with the most to gain from the medicines, the rate of use barely reaches 53 percent.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
MARCH 2010 proved to change the diet industry forever when HCG Platinum launched their product in Anaheim, California at the Natural Products Expo West. With growing consumer concerns about credible weight loss products, Platinum perfected the HCG hormone diet by adding three amino acids to the formula, making it not only the most effective diet product on the market, but also the safest.
The loss of a gene known as INPP5A could predict the onset, and track the progression, of an aggressive type of skin cancer, according to a study published today by the Mayo Clinic, Arizona Cancer Center, and the Translational Genomics Research Institute (TGen).
› Verified 5 days ago
| Entity Name | Maine Medical Partners |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285738310 PECOS PAC ID: 9335043967 Enrollment ID: O20040525000396 |
News Archive
Scientists at the University of Liverpool, supported by the British Heart Foundation, are studying blood flow in the brain to further medical understanding of cardiovascular disease.
...despite the fact that virtually all of them could benefit from those drugs, a new University of Michigan study finds. And even among those with the most to gain from the medicines, the rate of use barely reaches 53 percent.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
MARCH 2010 proved to change the diet industry forever when HCG Platinum launched their product in Anaheim, California at the Natural Products Expo West. With growing consumer concerns about credible weight loss products, Platinum perfected the HCG hormone diet by adding three amino acids to the formula, making it not only the most effective diet product on the market, but also the safest.
The loss of a gene known as INPP5A could predict the onset, and track the progression, of an aggressive type of skin cancer, according to a study published today by the Mayo Clinic, Arizona Cancer Center, and the Translational Genomics Research Institute (TGen).
› Verified 5 days ago
| Entity Name | Mid Coast Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1932164795 PECOS PAC ID: 5496739468 Enrollment ID: O20040623001212 |
News Archive
Scientists at the University of Liverpool, supported by the British Heart Foundation, are studying blood flow in the brain to further medical understanding of cardiovascular disease.
...despite the fact that virtually all of them could benefit from those drugs, a new University of Michigan study finds. And even among those with the most to gain from the medicines, the rate of use barely reaches 53 percent.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
MARCH 2010 proved to change the diet industry forever when HCG Platinum launched their product in Anaheim, California at the Natural Products Expo West. With growing consumer concerns about credible weight loss products, Platinum perfected the HCG hormone diet by adding three amino acids to the formula, making it not only the most effective diet product on the market, but also the safest.
The loss of a gene known as INPP5A could predict the onset, and track the progression, of an aggressive type of skin cancer, according to a study published today by the Mayo Clinic, Arizona Cancer Center, and the Translational Genomics Research Institute (TGen).
› Verified 5 days ago
| Entity Name | Mainehealth |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1790265502 PECOS PAC ID: 7517860588 Enrollment ID: O20040701000166 |
News Archive
Scientists at the University of Liverpool, supported by the British Heart Foundation, are studying blood flow in the brain to further medical understanding of cardiovascular disease.
...despite the fact that virtually all of them could benefit from those drugs, a new University of Michigan study finds. And even among those with the most to gain from the medicines, the rate of use barely reaches 53 percent.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
MARCH 2010 proved to change the diet industry forever when HCG Platinum launched their product in Anaheim, California at the Natural Products Expo West. With growing consumer concerns about credible weight loss products, Platinum perfected the HCG hormone diet by adding three amino acids to the formula, making it not only the most effective diet product on the market, but also the safest.
The loss of a gene known as INPP5A could predict the onset, and track the progression, of an aggressive type of skin cancer, according to a study published today by the Mayo Clinic, Arizona Cancer Center, and the Translational Genomics Research Institute (TGen).
› Verified 5 days ago
| Entity Name | Penobscot Bay Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982645305 PECOS PAC ID: 2163320508 Enrollment ID: O20060316000020 |
News Archive
Scientists at the University of Liverpool, supported by the British Heart Foundation, are studying blood flow in the brain to further medical understanding of cardiovascular disease.
...despite the fact that virtually all of them could benefit from those drugs, a new University of Michigan study finds. And even among those with the most to gain from the medicines, the rate of use barely reaches 53 percent.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
MARCH 2010 proved to change the diet industry forever when HCG Platinum launched their product in Anaheim, California at the Natural Products Expo West. With growing consumer concerns about credible weight loss products, Platinum perfected the HCG hormone diet by adding three amino acids to the formula, making it not only the most effective diet product on the market, but also the safest.
The loss of a gene known as INPP5A could predict the onset, and track the progression, of an aggressive type of skin cancer, according to a study published today by the Mayo Clinic, Arizona Cancer Center, and the Translational Genomics Research Institute (TGen).
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John J Gullo, MD 5008 Brittonfield Pkwy, Suite 700, East Syracuse, NY 13057-9248 Ph: (315) 472-7504 | John J Gullo, MD 5008 Brittonfield Pkwy, Suite 700, East Syracuse, NY 13057-9248 Ph: (315) 472-7504 |
News Archive
Scientists at the University of Liverpool, supported by the British Heart Foundation, are studying blood flow in the brain to further medical understanding of cardiovascular disease.
...despite the fact that virtually all of them could benefit from those drugs, a new University of Michigan study finds. And even among those with the most to gain from the medicines, the rate of use barely reaches 53 percent.
Prostate cancer is the most common malignancy among men in the United States. It is also the second most common cause of cancer-related deaths. Despite improved treatments for prostate cancer, many patients with advanced disease eventually develop drug resistance.
MARCH 2010 proved to change the diet industry forever when HCG Platinum launched their product in Anaheim, California at the Natural Products Expo West. With growing consumer concerns about credible weight loss products, Platinum perfected the HCG hormone diet by adding three amino acids to the formula, making it not only the most effective diet product on the market, but also the safest.
The loss of a gene known as INPP5A could predict the onset, and track the progression, of an aggressive type of skin cancer, according to a study published today by the Mayo Clinic, Arizona Cancer Center, and the Translational Genomics Research Institute (TGen).
› Verified 5 days ago
Anthony J Scalzo, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5008 Brittonfield Pkwy, Suite 700, East Syracuse, NY 13057 Phone: 315-472-7504 Fax: 315-479-8639 | |
Marcel Daniel Bingham, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5008 Brittonfield Pkwy, Suite 700, East Syracuse, NY 13057 Phone: 315-472-7504 Fax: 315-479-8639 | |
Angelie D Roman, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5008 Brittonfield Pkwy, Suite 700, East Syracuse, NY 13057 Phone: 315-472-7504 Fax: 315-479-8639 | |
Steven V Zygmont, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5000 Brittonfield Pkwy Ste A100, East Syracuse, NY 13057 Phone: 315-449-3800 Fax: 315-449-0558 | |
David A Churchill, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 5008 Brittonfield Pkwy, Suite 700, East Syracuse, NY 13057 Phone: 315-472-7504 Fax: 315-479-8639 | |
Dr. Steven M Duffy, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5008 Brittonfield Pkwy Ste 700, East Syracuse, NY 13057 Phone: 315-472-7504 Fax: 315-634-4677 | |
Ms. Brooke Nicole Binion, PA-C Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5008 Brittonfield Pkwy Ste 700, East Syracuse, NY 13057 Phone: 315-472-7504 |